Mechanism of unusual formation of 3-(5-phenyl-3H-[1,2,4]dithiazol-3-yl)chromen-4-ones and 4-oxo-4H-chromene-3-carbothioic acid N-phenylamides and their antimicrobial evaluation

European Journal of Medicinal Chemistry

Volumn 44, Issue 8, 2009, Pages 3209-3216

  Raj, Tilak ^a   Bhatia, Richa Kaur ^a   Sharma, Rakesh Kumar ^a   Gupta, Vivek ^b   Sharma, Deepak ^b   Ishar, Mohan Paul Singh ^a  

^a GURU NANAK DEV UNIVERSITY   (India)

^b UNIVERSITY OF JAMMU   (India)

Author keywords

Antibacterial activity; Antifungal activity; Dithiazoles; N Phenylthioamide

Indexed keywords

1,2,4 DITHIAZOLE DERIVATIVE; 3 (5 PHENYL 3H [1,2,4]DITHIAZOL 3 YL)CHROMEN 4 ONE; 4 OXO 4H CHROMENE 3 CARBOTHIOIC ACID N PHENYLAMIDE; CHLORAMPHENICOL; CHROMONE DERIVATIVE; CIPROFLOXACIN; FLUCONAZOLE; THIAZOLE DERIVATIVE; THIOBENZAMIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CANDIDA TROPICALIS; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; GEOTRICHUM CANDIDUM; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS AERUGINOSA; SHIGELLA FLEXNERI; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

AMIDES; ANTI-INFECTIVE AGENTS; BACTERIA; CHROMONES; CRYSTALLOGRAPHY, X-RAY; FUNGI; MICROBIAL SENSITIVITY TESTS; SPECTRUM ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 67349159700     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.03.030     Document Type: Article

References (34)

1. Smith H.J. Introduction to the Principles of Drug Design and Action. fourth ed. (2006), Taylor Francis pp. 567-614
2. Ruiz-Herrera, and San-Blas G. Current Drug Targets - Infectious Disorders vol. 3 (2003), Bentham Science Publishers 77-91
3. Gilman A.G. The Pharmacological Basis of Therapeutic. tenth ed. (2001), McGraw-Hill Sec. VIII, pp. 1141-1310
4. Mascaretti O.A. Bacteria versus Antibacterial Agents: An Integrated Approach (2003), ASM Press p. 321
5. Laura G., Marinella R., and Daniela P. Mini Rev. Med. Chem. 7 (2007) 481-489
6. Bakavoli M., Nikapour M., Rahimizadeh M., Saberi M.R., and Sadeghian H. Bioorg. Med. Chem. 15 (2007) 2120-2126
7. Niewiadomy A.E., Kulak K., Lukaszuk C., Matysiak J., and Kostecka M. Rocz. Akad. Med. Bialymst. 50 (2005) 31-35
8. Cottenceau G., Besson T., Gautier V., Rees C.W., and Pons A.-M. Bioorg. Med. Chem. Lett. 6 (1996) 529-532
9. Baraldi P.G., Pavani M.G.M.G., Nuñez M.C., Brigidi P., Vitali B., Gambari R., and Romagnoli R. Bioorg. Med. Chem. 10 (2002) 449-456
10. Besson T., Rees C.W., Cottenceau G., and Pons A.M. Bioorg. Med. Chem. Lett. 6 (1996) 2343-2348
11. Thiery V., Rees C.W., Besson T., Cottenceau G., and Pons A.-M. Eur J. Med. Chem. 33 (1998) 149-153
12. Pluijgers C.W., Vonk J.W., and Thorn G.D. Tetrahedron Lett. 12 (1971) 1317-1318
13. Allen R.E., Shelton R.S., and Van Campen M.G. J. Am. Chem. Soc. 76 (1954) 1158-1159
14. Turner W.B., and Aldridge D.C. Fungal Metabolites - II (1983), Acedamic Press Inc., New York p. 152
15. Alam S. J. Chem. Sci. 116 (2004) 325-331
16. Raj T., Ishar M.P.S., Gupta V., Pannu A.P.S., Kanwal P., and Singh G. Tetrahedron Lett. 49 (2008) 243-246
17. Shimada K., Aikawa K., Fujita T., Sato M., Goto K., Aoyagi S., Takikawa Y., and Kabuto C. Bull. Chem. Soc. Jpn. 74 (2001) 511-525
18. Rafiqul I.M., Shimada K., Aoyagi S., Fujisawa Y., and Takikawa Y. Tetrahedron Lett. 45 (2004) 6187-6190
19. Meslin J.C., and Quiniou H. Tetrahedron 31 (1975) 3055-3058
20. Sabita G. Aldrichim. Acta 29 (1996) 15-25
21. Singh G., Singh R., Girdhar N.K., and Ishar M.P.S. Tetrahedron 58 (2002) 2471-2480
22. The data for 17c has been submitted to The Cambridge Crystallographic Data Centre (CCDC No. 702090).
23. Klimesova V., Svoboda M., Waisser K., Machacek M., Buchta V., and Odlerova Z. Arch. Pharm. 329 (1996) 438-442
24. Wang F., Langley R., Gulten G., Dover L.G., Besra G.S., Jacobs Jr. W.R., and Sacchettini J.C. J. Exp. Med. 204 (2007) 73-78
25. Ishar M.P.S., Singh G., Singh S., Sreenivasan K.K., and Singh G. Bioorg. Med. Chem. Lett. 16 (2006) 1366-1370
26. Pommier Y., and Tanizawa A. In: Hickman J., and Tritton T. (Eds). Cancer Chemotherapy (1993), Blackwell Scientific Publications Ltd, Oxford 214-250
27. Chen A.Y., and Liu L.F. Annu. Rev. Pharmacol. Toxicol. 94 (1994) 194-218
28. Zewail-Foote M., and Hurley L. Anti-Cancer Drug Des. 14 (1999) 1-9
29. MacDonald T.L., Lehnert E.K., Loper J.T., Chow K.C., and Ross W.E. In: Potmesil M., and Kohn K.W. (Eds). DNA Topoisomerase in Cancer (1991), Oxford University Press, New York 119 (Chapter 2)
30. Gootz T.D., and Birghty K.E. Chemistry and Mechanism of Action of the Quinolone Antibacterials. In: Andriole V.T. (Ed). The Quinolones. second ed. (1998), Academic Press, San Diego, CA 27-80
31. Cianchetta G., Mannhold R., Cruciani G., Baroni M., and Cecchetti V. J. Med. Chem. 47 (2004) 3193-3201
32. Mitic-Ćulafic D., Vukovic-Gacic B., Knezevic-Vukcevic J., Stankovic S., and Simic D. Arch. Biol. Sci. 57 (2005) 173-178
33. Fromtling R.A., Galgiani J.N., Pfaller M.A., Espinel-Ingroff A., Bartizal K.F., Bartlett M.S., Body B.A., Frey C., Hall G., Roberts G.D., Nolte F.B., Odds F.C., Rinaldi M.G., Sugar A.M., and Villareal K. Antimicrob. Agents Chemother. 37 (1993) 39-45
34. Hindler J. In: Mahon C.C., and Manuselis G. (Eds). Textbook of Diagnostic Microbiology Special Antimicrobial Susceptibility Tests (1995) 89-96